Yn dangos 46 i 60 o 171 canlyniadau
Joint statement on meeting regulatory standards during periods of global or national shortage of medicines
We are concerned to hear that people with Type 2 diabetes are experiencing problems accessing GLP-1 receptor agonists (GLP-1 RAs).
Do you have safety concerns?
As an HCPC-registered practitioner, one of your responsibilities is to be alert to public safety risks, breaches of legislation and wrongdoing
HCPC response to DHSC healthcare regulation consultation
As we move forward with the wider programme of regulatory reform, we welcome this consultation to consider how the powers to introduce and remove professions from regulation might be used in the future.